The Daily Pennsylvanian is a student-run nonprofit.

Please support us by disabling your ad blocker on our site.

Penn Gene Therapy Program Director James Wilson will leave the University following the transfer of Penn Medicine’s Gene Therapy Program to two new for-profit companies: GEMMA Biotherapeutics and Franklin Biolabs.